Lynda Palubeski

Oncology Resource Group serves pharmaceutical and biotechnology developers worldwide by delivering best-in-class market planning and competitive intelligence reports through ONCrg's 11 expert advisors in 13 solid tumor, 6 hematologic malignancy and emerging + late stage immuno-oncology drug markets.